Editorial: Aldose reductase inhibition for the treatment of asthma

Expert Review of Clinical Immunology

Volumn 6, Issue 1, 2010, Pages 1-4

  Srivastava, Satish K ^a   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; CYTOKINE; EPALRESTAT; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 4; INTERLEUKIN 5; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; ENZYME INHIBITOR;

ASTHMA; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM;

ALDEHYDE REDUCTASE; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; ENZYME INHIBITORS; HUMANS;

EID: 77649136736     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.79     Document Type: Editorial

References (27)

1. Dimov VV, Stokes JR, Casale TB. Immunomodulators in asthma therapy. Curr. Allergy Asthma Rep. 9(6), 475-483 (2009).
2. Apter AJ. Advanc es in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008. J. Allergy Clin. Immunol. 123(1), 35-40 (2009).
3. Janssen-Heininger YM, Poynter ME, Aesif SW et al. Nuclear factor kB, airway epithelium, and asthma: avenues for redox control. Proc. Am. Thorac. Soc. 6(3), 249-255 (2009).
4. Edwards MR, Bartlett NW, Clarke D et al. Targeting the NF-kB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 121(1), 1-13 (2009).
5. Hilberg T. Etiology of exercise-induced asthma: physical stress-induced transcription. Curr. Allergy Asthma Rep. 7(1), 27-32 (2007).
6. Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev. 26(3), 380-392 (2005).
7. Alexiou P, Pegklidou K, Chatzopoulou M et al. Aldose reductase enzyme and its implication to major health problems of the 21(st) Century. Curr. Med. Chem. 16(6), 734-752 (2009).
8. Oates PJ. Aldose reductase, still a compelling target for diabetic neuropathy. Curr. Drug Targets. 9(1), 14-36 (2008).
9. Suzen S, Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Curr. Med. Chem. 10(15), 1329-1352 (2003).
10. Barth BM, Stewart-Smeets S, Kuhn TB. Proinfl ammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol. Cell Neurosci. 41(2), 274-285 (2009).
11. Zhao H, Ma JK, Barger MW et al. Reactive oxygen species- and nitric oxide-mediated lung infl ammation and mitochondrial dysfunc tion in wild-type and iNOSdeficient mice exposed to diesel exhaust particles. J. Toxicol. Environ. Health A. 72(8), 560-570 (2009).
12. LoPachin RM, Gavin T, Petersen DR, Barber DS. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol. 22(9), 1499-1508 (2009).
13. Srivastava S, Chandra A, Bhatnagar A et al. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 217(3), 741-746 (1995).
14. Srivastava S, Watowich SJ, Petrash JM et al. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38(1), 42-54 (1999).
15. Dixit BL, Balendiran GK, Watowich SJ et al. Kinetic and structural characterization of the glutathione-binding site of aldose reductase. J. Biol. Chem. 275(28), 21587-21595 (2000).
16. Ramana KV, Dixit BL, Srivastava S et al. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 39(40), 12172-12180 (2000).
17. Singh R, White MA, Ramana KV et al. Structure of a glutathione conjugate bound to the active site of aldose reductase. Proteins 64(1), 101-110 (2006).
18. Ramana KV, Bhatnagar A, Srivastava S et al. Mitogenic responses of vascular smooth muscle cells to lipid peroxidationderived aldehyde 4-hydroxy-trans-2- nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem. 281(26), 17652-17660 (2006).
19. Ramana KV, Fadl AA, Tammali R et al. Aldose reductase mediates the lipopolysacc haride-induced release of infl ammatory mediators in RAW264.7 murine macrophages. J. Biol. Chem. 281(44), 33019-33029 (2006).
20. Ramana KV, Willis MS, White MD et al. Endotoxin-induced cardiomyopathy and systemic infl ammation in mice is prevented by aldose reductase inhibition. Circulation 114(17), 1838-1846 (2006)
21. Boldogh I, Bacsi A, Choudhury BK et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigeninduced allergic airway infl ammation. J. Clin. Invest. 115(8), 2169-2179 (2005).
22. Park CS, Kim TB, Lee KY et al. Inc reased oxidative stress in the airway and development of allergic infl ammation in a mouse model of asthma. Ann. Allergy Asthma Immunol. 103(3), 238-247 (2009).
23. Yadav UC, Ramana KV, Aguilera-Aguirre L et al. Inhibition of aldose reductase prevents experimental allergic airway infl ammation in mice. PLoS One 4(8), e6535 (2009).
24. Yadav UC, Naura AS, Aguilera-Aguirre L et al. Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway infl ammation in ovalbumin-induced asthma in mice. J. Immunol. 183(7), 4723-4732 (2009).
25. Yadav UC, Srivastava SK, Ramana KV. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 48(10), 4634-4642 (2007).
26. Tammali R, Ramana KV, Singhal SS et al. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon canc er cells. Cancer Res. 66(19), 9705-9713 (2006).
27. Tammali R, Reddy AB, Ramana KV et al. Aldose reductase deficienc y in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation. Carcinogenesis 30(5), 799-807 (2009).